TIPRL accelerates liver cancer aggressiveness via the upregulation of the microtubule-associated protein light chain 3 (LC3), an autophagy marker, and CD133 (Prominin-1) expression [8]. The gene discussed is MAP1LC3A; the disease is liver cancer.